Objective To explore the single and combined predictive value of clinical data,gadolinium-ethoxybenzyl-di-ethylenetriamine pentaacetic acid(Gd-EOB-DTPA)enhanced MRI features and radiomics methods for microvascular inva-sion(MVI)in patients with single hepatocellular carcinoma(HCC).Methods This study included 110 patients with HCC(training set:77 cases,validation set:33 cases).The clinical data of the patients were analyzed,the MRI imaging fea-tures were evaluated,and the intratumoral imaging features were extracted from arterial phase,portal venous phase and de-layed phase respectively.The least absolute shrinkage selection operator(LASSO)algorithm was used for feature selection.Then logistic regression analysis was used to construct clinical model,imaging model,single sequence radiomics model,com-bined radiomics model and clinical-imaging-radiomics model,and evaluate the performance of different models.Results Of the 110 patients,48 cases(43.6%)were confirmed by pathology to have MVI.In the training set,there were significant differences in age in MVI state(P<0.05).In the training set and validation set,γ-glutamyl transpeptidase(γ-GT)、peritu-moral enhancement on arterial phase,peritumoral hypointensity on hepatobiliary phase were strong predictors of MVI(P<0.05).Through the LASSO algorithm,this study finally selected 17 radiomics features related to MVI.Among the three sin-gle sequence radiomics models,the radiomics model based on portal vein phase images had the best ability to predict the MVI of HCC patients,and its AUC in training set and validation set is 0.788 and 0.699 respectively.Finally,the clinical-imaging-radiomics model showed high efficiency in the training set,with AUC of 0.895(95%CI:0.827~0.963),specifici-ty of 0.744 and sensitivity of 0.912.Conclusion This study established a combined model based on clinical data,Gd-EOB-DTPA enhanced MRI imaging features and multiple sequences radiomics features,and verified its value of non-invasive prediction of MVI in patients with HCC before operation,which may be used as a clinical tool to guide follow-up individual-ized treatment.